FES and acute myeloid leukemia: TAE-684 also displayed identical results to those obtained with the Flt3-ITD+ AML cells, as it inhibited Fes but had no effect on Flt3-ITD, despite inhibitory activity against the Flt3-ITD kinase domain in vitro.